Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
597
-
Total 13F shares, excl. options
-
50.6M
-
Shares change
-
-198K
-
Total reported value, excl. options
-
$10.6B
-
Value change
-
-$29.7M
-
Put/Call ratio
-
1.06
-
Number of buys
-
305
-
Number of sells
-
-269
-
Price
-
$210.25
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q2 2023
699 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2023.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 597 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.6M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (5.92M shares), BlackRock Inc. (5.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.5M shares), STATE STREET CORP (2.09M shares), Clearbridge Investments, LLC (1.75M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.68M shares), Allspring Global Investments Holdings, LLC (1.19M shares), GEODE CAPITAL MANAGEMENT, LLC (1.1M shares), ARIEL INVESTMENTS, LLC (1.05M shares), and MACKENZIE FINANCIAL CORP (919K shares).
This table shows the top 597 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.